JENBURKT PHARMACEUTICAL L Share Price

JENBURKT PHARMACEUTICAL L Share Price

NSE: JENBURPH
|
Pharmaceuticals
|
S Cap
₹ 952.00
-₹5.20 (-0.54%)
1D
Last updated 23 Sep, 2026, 15:59 IST

JENBURKT PHARMACEUTICAL L Share Price Today

As of 24 Sep 2026, JENBURKT PHARMACEUTICAL L share price is ₹952.00. The stock opened at ₹961.30, compared to its previous close of ₹957.20. During today's trading session, JENBURKT PHARMACEUTICAL L share price moved in the range of ₹930.00 to ₹979.80, with an average price of ₹954.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹930.00 and a high of ₹1,073.90. On the performance front, JENBURKT PHARMACEUTICAL L share price has declined by 8.45% over the last six months and is down 8.45% on a year-on-year basis.

₹930.00
0.54% down today
₹979.80
1D LOW
1D HIGH

JENBURKT PHARMACEUTICAL L Returns Calculator

Circuit
L
H
₹765.80
₹1,148.60
52-week
L
H
₹930.00
₹1,073.90

About JENBURKT PHARMACEUTICAL L

JENBURKT PHARMACEUTICAL L Share Price
ISIN
INE354A01013
Sector Market Cap
₹ 421.96 Cr

Jenburkt Pharmaceuticals Limited is an India-based company that is engaged in the business of manufacturing, producing, developing and marketing a range of branded pharmaceuticals and healthcare products. The Company offers pharmaceutical products for various therapeutic areas, including analgesic and antipyretics, anthelmintics, anti-arthritics, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer products, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. The Company's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets, Topcal-M Tablets, Powergesic, ZIX P Tablet, and others. The Company's manufacturing plant is in Sihor, Gujarat.

JENBURKT PHARMACEUTICAL L Financial Highlights

  • Revenue: JENBURKT PHARMACEUTICAL L reported revenue of ₹179.04 crore in FY26 vs ₹158.41 crore in FY25. It showed an increase of 13.02% on a yearly basis.
  • Operating Profit: JENBURKT PHARMACEUTICAL L reported an operating profit of ₹46.52 crore in FY26 vs ₹43.93 crore in FY25. It showed an increase of 5.90% on a year-on-year basis.
  • Net Profit: JENBURKT PHARMACEUTICAL L reported a net profit of ₹34.74 crore in FY26 vs ₹32.06 crore in FY25. It showed an increase of 8.36% on a yearly basis.

JENBURKT PHARMACEUTICAL L Quarterly Result Highlights

  • JENBURKT PHARMACEUTICAL L reported revenue of ₹37.02 crore in Jun 2026, compared with ₹48.98 crore in Mar 2026, representing a decrease of 24.42% on a quarter-on-quarter (QoQ) basis.
  • JENBURKT PHARMACEUTICAL L reported an operating profit of ₹6.77 crore in Jun 2026, compared with ₹13.71 crore in Mar 2026, representing a decrease of 50.62% on a quarter-on-quarter (QoQ) basis.
  • JENBURKT PHARMACEUTICAL L reported a profit of ₹5.89 crore in Jun 2026, compared with ₹10.85 crore in Mar 2026, reflecting a decrease of 45.71% on a QoQ basis.
  • The earnings per share (EPS) of JENBURKT PHARMACEUTICAL L stood at ₹78.71 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
46.62%
FII
0.00%
Other DII
0.12%
Retail and other
53.26%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
421.96
P/E
12.88
P/B
2.15
ROE
17.63%
D/E
0.01
ROCE
23.20%
Div. Yield
2.16%
EPS(TTM)
78.71
Turnover
0.75
EV/EBITDA
7.98
Net Margin
20.59%
Op. Margin
29.68%
ROA
14.53%
Quick Ratio
3.52
Curr. Ratio
4.23
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Jenburkt Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Jenburkt Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

JENBURKT PHARMACEUTICAL L Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹168.74₹151.69₹141.97₹136.75
Other Income₹10.30₹6.72₹4.67₹5.12
Total Revenue₹179.04₹158.41₹146.63₹141.87
Total Expenses₹128.57₹114.48₹111.46₹109.01
Profit Before Tax₹46.52₹43.93₹35.18₹32.86
Tax₹11.78₹11.87₹9.20₹8.26
Profit After Tax₹34.74₹32.06₹25.98₹24.61
EPS - Basic₹78.71₹72.65₹58.86₹53.90
EPS - Diluted₹78.71₹72.65₹58.86₹53.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹34.74₹32.06₹25.98₹24.61
Income before WC changes₹41.30₹40.85₹34.60₹31.33
Change in Assets-₹5.09-₹2.88-₹18.12-₹0.65
Change in Liabilities₹2.10₹3.37-₹0.10-₹5.40
Change in WC-₹2.99₹0.49-₹18.22-₹6.05
Cash flow from Operations₹26.52₹27.91₹8.12₹17.05
Cash flow from Investing-₹19.45-₹17.04-₹0.58₹2.62
Cash flow from Financing-₹8.86-₹7.62-₹7.08-₹21.04
Total Cash Flow-₹1.79₹3.24₹0.47-₹1.37
Cash (Start of the year)₹7.36₹4.13₹3.66₹5.03
Cash (End of the year)₹5.58₹7.36₹4.13₹3.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹130.92₹139.65₹55.37₹60.72
Current Assets₹95.09₹56.53₹109.73₹81.09
Total Assets₹226.01₹196.19₹165.10₹141.81
Current Liabilities₹23.15₹18.82₹16.38₹15.76
Net Current Asset₹71.94₹37.71₹93.35₹65.33
Non-Current Liabilities₹5.83₹5.59₹3.78₹3.66
Equity Capital₹197.04₹171.78₹144.94₹122.39
Total Equity & Liabilities₹226.01₹196.19₹165.10₹141.81
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
952
65
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 65
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
42.62
Neutral
ATR (14)
35.24
Neutral
STOCH(9,6)
18.8
Bullish
ADX(9)
46.55
Bearish
ROC(12)
-8.36
Bearish
WillR(14)
-82.68
Bullish
Period
Simple value
Exponential vaue
5D
970.42
968.62
10D
987.26
984.85
20D
1014.99
973
50D
1022.61
0
100D
1022.61
0
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
JENBURKT PHARMACEUTICAL L Share Price
JENBURKT PHARMACEUTICAL L
Pharmaceuticals
Add Stock
Add Another

JENBURKT PHARMACEUTICAL L Share Price FAQs

JENBURKT PHARMACEUTICAL L share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837